Home Cardiac (non-arrest) Aortic emergencies: HR/BP drugs in transport
Cardiac (non-arrest)
Aortic emergencies: HR/BP drugs in transport
Medical Management of Aortic Emergencies in Critical Care Transport
Prehospital Emergency Care · Added 22 September 2026
Cohort of 1,530 aortic emergencies in US critical care transport — esmolol, labetalol and nicardipine strategies hit HR/BP targets at similar rates, with esmolol alone showing the highest hypotension incidence (9.3%) and labetalol alone the lowest (2.1%)
- Study type
- Cohort
- Design
- Retrospective cohort of US critical care transport encounters
- Participants
- 1,530 adults with aortic emergencies
- Main finding
- All drug strategies achieved target HR/SBP similarly; hypotension lowest with labetalol alone (2.1%) and highest with esmolol (9.3%); esmolol/nicardipine combination had lowest tachycardia (11.0%)
- Caveat
- Retrospective design; US critical care transport setting not directly applicable to Australian paramedic practice
- Bottom line
- Context only
Why it matters in Australia (Low relevance). transferability — critical-care transport scope built on infusions; beta-blockers aren't in the extracted ACTAS formulary (only QAS carries them interstate) — background awareness only
Learning goal
Weigh the hypotension risks of different heart rate and blood pressure control strategies in suspected aortic emergencies.
More
- Topic: Cardiac (non-arrest)
- Daily scan: 22 September 2026
Related papers on Cardiac (non-arrest)
-
Only 60% of paramedic-suspected STEMI confirmed
A retrospective Victorian statewide ambulance registry cohort (2020–25) followed up paramedic-suspected STEMI presentations and found STEMI confirmed in only 60% of those with a recorded discharge diagnosis, with 30-day mortality of 6.5%.
-
Prehospital STEMI data transmission speeds reperfusion
In 409 Chinese STEMI patients, prehospital WeChat transmission of patient data to the PCI centre shortened symptom-to-first-medical-contact (75 vs 120 minutes), door-to-balloon (50 vs 67 minutes) and total ischaemic time (121.5 vs 150 minutes).
-
48-hour AF cardioversion threshold abandoned
EMA commentary arguing the once-conventional 48-hour elective cardioversion threshold for recent-onset atrial fibrillation is no longer supported
-
LLMs unreliable for cath-lab activation ECGs
Retrospective test of three multimodal LLMs against real cardiology cath-lab activation decisions on 615 prehospital ECGs found the best (Gemini, 95.3% sensitivity) had 9.4% specificity, and the standard ECG machine algorithm beat all three LLMs overall — general-purpose LLMs aren't reliable for STEMI pathway activation.